Patients with COPD plus a depression/anxiety disorder had poorer scores related to disease burden and health-related quality of life, according to data published in Chronic Obstructive Pulmonary ...
EMA accepts for review GSK’s application to expand use of Nucala for COPD treatment: London, UK Wednesday, March 26, 2025, 11:00 Hrs [IST] GSK plc announced that the European Me ...
Despite the promising market growth, regulatory compliance and stringent guidelines continue to pose challenges for MDI ...
Genetic factors may affect the functional status of patients with chronic obstructive pulmonary disease (COPD).
Dr. Chengfeng Fu, a lung specialist from Chongqing, China, led the study. He said, “Our study demonstrated an increased risk of all-cause and cardiovascular disease mortality in people who had COPD ...
Inhaled corticosteroids (ICS) are commonly prescribed for chronic obstructive pulmonary disease (COPD), but not recommended ...
Background: This editorial builds on a study by Brulin and Teoh, released ahead of the March/April 2025 issue of Annals of Family Medicine, which found that performance-based reimbursement is ...
A retrospective study found that cannabis users were six times as likely to have a heart attack compared to non-users, while ...
Eli Lilly, Adaptimmune, Aurion Biotech, and ImmunityBio had breakthrough medicines and therapies debut in the past year.
Dupilumab added to standard COPD triple therapy reduces the annual rate of moderate exacerbations but not severe exacerbations.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback